Clinical Trial Detail

NCT ID NCT01218555
Title Study of Everolimus (RAD001)in Combination With Lenalidomide
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Emory University
Indications

Advanced Solid Tumor

Therapies

Lenalidomide

Everolimus

Age Groups: senior adult

No variant requirements are available.